HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zafar Ali Selected Research

Brachydactyly type C

7/2021A GDF5 frameshift mutation segregating with Grebe type chondrodysplasia and brachydactyly type C+ in a 6 generations family: Clinical report and mini review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zafar Ali Research Topics

Disease

4Neoplasms (Cancer)
11/2019 - 01/2011
2Microcephaly
01/2019 - 10/2017
1Edema (Dropsy)
02/2022
1Type 2 Diabetes Mellitus (MODY)
09/2021
1Hypertension (High Blood Pressure)
09/2021
1Grebe type Chondrodysplasia
07/2021
1Brachydactyly type C
07/2021
1Thrombosis (Thrombus)
01/2020
1Ischemic Stroke
01/2020
1Stroke (Strokes)
01/2020
1Rhabdoid Tumor (Rhabdoid Tumors)
11/2019
1Rhabdomyosarcoma
11/2019
1Langerhans Cell Sarcoma
11/2019
1Melanoma (Melanoma, Malignant)
11/2019
1Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
09/2019
1Thrombocytopenia (Thrombopenia)
01/2019
1Disease Progression
04/2018
1Mucormycosis
04/2018
1Atrophy
12/2017
1Colonic Polyps
01/2017
1Carcinoma (Carcinomatosis)
11/2016
1Papillary Carcinoma
11/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2016
1Dwarfism
12/2014
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2014
1Typhoid Fever (Typhoid)
05/2012
1Blindness (Hysterical Blindness)
05/2012
1Meningitis
05/2012
1Communicable Diseases (Infectious Diseases)
05/2012
1Pain (Aches)
11/2011
1Hepatitis B
01/2011

Drug/Important Bio-Agent (IBA)

2Mucin-1 (CA 15-3 Antigen)IBA
11/2019 - 11/2019
2Proteins (Proteins, Gene)FDA Link
09/2019 - 01/2019
2Biomarkers (Surrogate Marker)IBA
03/2018 - 09/2016
1Diclofenac (SR 38)FDA LinkGeneric
02/2022
1SolutionsIBA
02/2022
1Pharmaceutical PreparationsIBA
02/2022
1Triglycerides (Triacylglycerol)IBA
09/2021
1Growth Differentiation Factor 5IBA
07/2021
1AnticoagulantsIBA
01/2020
1Warfarin (Coumadin)FDA LinkGeneric
01/2020
1MyogeninIBA
11/2019
1DesminIBA
11/2019
1AntigensIBA
11/2019
1Heparin (Liquaemin)FDA LinkGeneric
01/2019
1Amphotericin B (Amphotericin)FDA LinkGeneric
04/2018
1isavuconazoleIBA
04/2018
1ChromatinIBA
03/2018
1Factor VII (Proconvertin)IBA
03/2018
1Serine (L-Serine)FDA Link
12/2017
1serum P-component (CIt)IBA
10/2017
1SultanIBA
01/2017
1erucylphosphocholineIBA
11/2016
1Phosphotransferases (Kinase)IBA
12/2014
1Imatinib Mesylate (Gleevec)FDA Link
09/2014
1Anti-Bacterial Agents (Antibiotics)IBA
05/2012
1A 17 (A-17)IBA
11/2011
1Eosine Yellowish-(YS) (Eosin)IBA
01/2011
1AntibodiesIBA
01/2011

Therapy/Procedure

1Critical Care (Surgical Intensive Care)
01/2019
1Salvage Therapy
04/2018
1Debridement
04/2018